New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
RadNet, Inc.
RDNT
Shape
US Flag

NASDAQ

5B

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

5B

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

68.58USD
Shape-0.66 ( -0.95%)
Market Open
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated October 3, 2024
1W -0.98 % 1M 9.47 % 3M 15.13 % 1Y 139.95 %

Key Metrics

Shape
  • Market Cap

    5.07B


  • Shares Outstanding

    73.96M


  • Share in Float

    63.93M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    68.58


  • Average Volume

    593623


  • Beta

    1.744


  • Range

    25.11-71.919


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.radnet.com


  • Sector

    Healthcare


Fundamentals

Shape

120.44x

P/E Ratio

2.99x

P/S Ratio

5.77x

P/B Ratio

1.2

Debt/Equity

0.6%

Net Margin

$0.2

EPS

How RDNT compares to sector?

P/E Ratio

Relative Strength

Shape

RDNT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape321%

2025-Revenue

$0.78

Shape2021%

2025-EPS

$363M

Shape419%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Barclays

upgrade

Previous: Equal-Weight

2024-09-06

Now: Overweight

Loop Capital Markets

initialise

Previous: Not converted

2023-03-31

Now: Buy

CJS Securities

initialise

Previous: Not converted

2023-03-31

Now: Outperform

B. Riley Securities

initialise

Previous: Not converted

2023-03-31

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-57%

0.09
vs 0.21

Q4.22

arrow
arrow

-15%

0.11
vs 0.13

Q1.23

arrow
arrow

N/A

-0.08
vs -0.15

Q2.23

arrow
arrow

+60%

0.24
vs 0.15

Q3.23

arrow
arrow

+56%

0.14
vs 0.09

Q4.23

arrow
arrow

+82%

0.2
vs 0.11

Q1.24

arrow
arrow

+188%

0.07
vs -0.08

Q2.24

arrow
arrow

-33%

0.16
vs 0.24

Q3.24

arrow
arrow

+13%

0.16
vs 0.14

Q4.24

arrow
arrow

+11%

0.22
vs 0.2

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

350M  vs 332.7M

Q4.22

arrow
arrow

+15%

383.9M  vs 333.1M

Q1.23

arrow
arrow

+14%

390.6M  vs 341.8M

Q2.23

arrow
arrow

+14%

403.7M  vs 354.4M

Q3.23

arrow
arrow

+15%

402M  vs 350M

Q4.23

arrow
arrow

+10%

420.4M  vs 383.9M

Q1.24

arrow
arrow

+11%

431.7M  vs 390.6M

Q2.24

arrow
arrow

+14%

459.7M  vs 403.7M

Q3.24

arrow
arrow

+8%

433.5M  vs 402M

Q4.24

arrow
arrow

+9%

460.1M  vs 420.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+2%

0.02
vs 0.04

Q4.22

arrow
arrow

+1%

0.01
vs 0.02

Q1.23

arrow
arrow

-4%

-0.04
vs 0.01

Q2.23

arrow
arrow

+1%

0.01
vs -0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.01

Q4.23

arrow
arrow

0%

-0.00
vs 0.03

Q1.24

arrow
arrow

0%

-0.00
vs -0.00

Q2.24

arrow
arrow

0%

-0.00
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

152

152
vs 152

NA

Q4.22

arrow
arrow

148

148
vs 152

-3%

Q1.23

arrow
arrow

155

155
vs 148

5%

Q2.23

arrow
arrow

193

193
vs 155

25%

Q3.23

arrow
arrow

197

197
vs 193

2%

Q4.23

arrow
arrow

224

224
vs 197

14%

Q1.24

arrow
arrow

280

280
vs 224

25%

Q2.24

arrow
arrow

281

281
vs 280

0%

Earnings Growth

Latest News